Here are five things to know:
1. Globus issued roughly $625 million of revenue guidance compared to the estimated $624.42 consensus revenue mark.
2. The company opened Wednesday, Feb. 28, 2017 at $27.81. Its one-year low is $19.25 and its one-year high is $28.86.
3. On Feb. 27, Globus reported $0.31 earnings per share for the quarter, missing the $0.33 estimate by $0.02. However, the company’s revenue of $151.59 million for the quarter exceeded analysts’ expectations of $149.30 million. Revenue for the quarter was up 6.3 percent on a year-over-year basis.
4. Zacks Investment Research, JMP Securities, Oppenheimer Holdings Inc., and William Blair recently cut shares of Globus.
5. One analyst has rated the company’s stock with a sell rating, 10 have given a hold rating and three have given a buy rating. Globus has a consensus price target of $25.60.
More device articles:
10 things to know about Stryker
Drs. Dom Coric, Michael Fehlings to present on INSPIRE study: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
